The Claim

In rodent models of Parkinson’s disease-like and Alzheimer’s disease-like pathology, administration of BPC 157 reduces motor deficits, cognitive impairment, and neurodegeneration, including preservation of nigrostriatal and hippocampal neuronal structures, through modulation of neurotransmitter systems and nitric oxide pathways.

Source: BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185

What the research says

Not yet evaluated

We are still looking at what the research says.

Supports
0score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In rodents with brain damage resembling Parkinson’s and Alzheimer’s diseases, BPC 157 reduces movement problems, memory loss, and neuron death, including in brain regions critical for movement and memory, by altering neurotransmitter activity and nitric oxide signaling.

See the scientific wording

In rodent models of Parkinson’s disease-like and Alzheimer’s disease-like pathology, BPC 157 administration counteracts motor deficits, cognitive impairment, and neurodegeneration, including protection of nigrostriatal and hippocampal regions, suggesting a potential neuroprotective effect mediated through modulation of neurotransmitter systems and nitric oxide.

Why this might work

BPC 157 adjusts nitric oxide levels to prevent too much or too little, while reducing harmful oxidative stress. This protects blood vessels and brain cells, allowing them to function normally. At the same time, BPC 157 fixes imbalances in brain chemicals like dopamine and acetylcholine that control movement and memory, preventing nerve cell death in areas critical for motor control and learning.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185

    In mice and rats with brain diseases like Parkinson’s and Alzheimer’s, a substance called BPC 157 helped them move better and remember more, while also protecting their brains from damage—without causing harm.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.